Each patient’s
immune signature,
decrypted
The immune system holds a vast amount of biological information that remains largely unexploited. Our research aims to read the hidden immune signature in every patient to support better clinical decisions.
PreCyte, our flagship product, is designed to measure a patient's immune response from a single blood draw to give surgical teams an objective infection risk score on day one after surgery.

Drawing on a decade of interdisciplinary research in France and at Stanford (USA), we have developed models that read the immune system at unprecedented depth, extracting robust biological signatures from complex immune datasets.
Our goal is to turn those signatures into solutions/products that help clinicians ground their decisions in objective data and deliver more personalized, proactive care to patients.
PreCyte is designed to translate a patient's immune response from a single blood draw into an objective infection risk score on day one after surgery, at the exact moment discharge and monitoring decisions are being made. With PreCyte, we aim to help surgical teams personalize postoperative care for each patient.




